Clinical Trial

Validation of Alcohol Level Identification Using DRIVESC

Completed
View on ClinicalTrials.gov →
Summary
This pilot study will evaluate the feasibility and acceptability of using a commercially available DRIVESC fitness-to-drive measurement tool to detect alcohol-induced impairment in healthy adult participants. The investigators hypothesize that DRIVESC can detect measurable changes in driving-related cognitive and motor performance across blood alcohol concentrations up to the U.S. per se legal limit of 0.08% g/210L ethanol. The study will enroll healthy adults aged 18-64 years (including both dosed and zero-alcohol arms) participating in the Wisconsin Breath Alcohol Examiner Specialist course, with each participant completing two study visits over two days.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-02.
Status change: Enrolling by Invitation → Completed 2026-02-23
Trial Details
NCT Number NCT07282405
Lead Sponsor University of Wisconsin, Madison
Conditions Driving Impaired
Enrollment 22 participants
Start Date 2025-11-11
Primary Completion 2026-02-04 (estimated)
Study Completion 2026-02-04 (estimated)
Updated on ClinicalTrials.gov 2026-02-27